Author Question: A client is beginning aldesleukin (Proleukin) therapy for advanced renal carcinoma. The nurse should ... (Read 76 times)

cdr_15

  • Hero Member
  • *****
  • Posts: 546
A client is beginning aldesleukin (Proleukin) therapy for advanced renal carcinoma. The nurse should monitor the client for:
 
  1. capillary leak syndrome.
  2. hypertension.
  3. hyperglycemia.
  4. hyperuricemia.

Question 2

What is the expected outcome for the client receiving filgrastim (Neupogen)?
 
  1. Increased white cell count
  2. Reduction in tumor size
  3. Reduction in paresthesia
  4. Increased platelet count



billybob123

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

Correct Answer: 1
Rationale 1: Capillary leak syndrome is a significant side effect of aldesleukin and can be fatal.
Rationale 2: Aldesleukin does not cause hypertension.
Rationale 3: Hyperglycemia is not a side effect of aldesleukin.
Rationale 4: Hyperuricemia is not a side effect of aldesleukin.
Global Rationale: Aldesleukin is a toxic drug that has the potential to cause serious adverse effects in virtually any organ system. Many of the adverse effects are caused by capillary leak syndrome, a serious condition in which plasma proteins and other substances leave the blood and enter the interstitial spaces because of porous capillaries. If not monitored carefully, capillary leak syndrome can result in death. The drug is not associated with hypertension, hyperglycemia, or hyperuricemia.

Answer to Question 2

Correct Answer: 1
Rationale 1: Filgrastim increases white cell counts.
Rationale 2: Filgrastim has no effect on tumor size.
Rationale 3: Filgrastim does not reduce paresthesia.
Rationale 4: Filgrastim has no effect on platelet counts.
Global Rationale: Filgastim is a colony-stimulating factor which stimulates the production of granulocytes. It has no effect on tumor size, does not reduce paresthesia, and has no effect on platelet counts.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Fungal nail infections account for up to 30% of all skin infections. They affect 5% of the general population—mostly people over the age of 70.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates's recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

Recent studies have shown that the number of medication errors increases in relation to the number of orders that are verified per pharmacist, per work shift.

Did you know?

Sildenafil (Viagra®) has two actions that may be of consequence in patients with heart disease. It can lower the blood pressure, and it can interact with nitrates. It should never be used in patients who are taking nitrates.

Did you know?

More than 150,000 Americans killed by cardiovascular disease are younger than the age of 65 years.

For a complete list of videos, visit our video library